Latest Breaking News On - Alnylam pharmaceuticals quarter - Page 1 : comparemela.com

Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.52272, expectations were $-0.75.

Rhode islandUnited statesTolga tangulerRaymond jamesMaury raycroftPushkal gargGary nachmanJeff poultonChristine lindenboomPaul matteisDavid lebowitzYvonne greenstreetAlnylam pharmaceuticals quarterCorporate communications at alnylamAlnylam pharmaceuticals incAlnylam pharmaceuticals